Parkinson’s disease is a brain disorder that causes unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and coordination.
“Identifying novel biomarkers and therapeutic targets for Parkinson’s disease”
A 2022 Parkinson’s Foundation-backed study revealed that nearly 90,000 people are diagnosed with Parkinson’s disease in the U.S. each year.
Out of the 85 species connected with having Parkinson’s, 55 were increased and 29 were decreased in people with Parkinson’s compared to healthy individuals. This study confirmed changes in the gut microbiomes seen in other studies, highlighting their role in the cause of Parkinson’s.
Adnexus currently discussing collaboration to Identifying novel biomarkers and therapeutic targets for Parkinson’s disease. Adnexus will utilize AI to analyze nutrition, genetics and microbiome to identify early predictors of the disease and novel therapies.